Yoshinori Yoshida News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yoshinori yoshida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yoshinori Yoshida Today - Breaking & Trending Today

Researchers identify molecule that activates cell cycle to enhance cardiac tissue graft production

Researchers identify molecule that activates cell cycle to enhance cardiac tissue graft production
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Manabu Kasamoto , Shunsuke Funakoshi , Yoshinori Yoshida , Stem Cell Reports , Professor Shunsuke Funakoshi , Associate Professor Yoshinori Yoshida ,

Altos Labs Announces Sponsored Research Agreement with Kyoto University's CiRA to Foster Cellular Rejuvenation Programming Research

/PRNewswire/ Altos Labs (Altos) today announced that it has signed a sponsored research agreement with the Center for iPS Cell Research and Application. ....

San Francisco Bay , United States , San Diego , United Kingdom , Shinya Yamanaka , Kim James , Finsbury Glover Hering , Knut Woltjen , Yoshinori Yoshida , Kazutoshi Takahashi , Morgan Warners , Altos Senior Scientific Advisor Shinya Yamanaka , Director Emeritus , Altos Labs , Professor Knut Woltjen , Professor Yoshinori Yoshida , Professor Kazutoshi Takahashi , Associate Professor Taro Toyoda , San Francisco Bay Area , Glover Hering , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Financing Agreements ,

Enhanced muscle regeneration using stem cells

Kyoto University
The Hidetoshi Sakurai laboratory reports two new markers that should advance iPS cell therapies for muscle degeneration.
Muscular dystrophy describes a group of muscle degenerative congenital diseases. The severity and rates differ between disease and patient, but in all cases the degeneration progresses, sometimes leaving patients in wheelchairs and unable to breathe without artificial respiration. With no present cure, scientists are experimenting with the transplantation of muscle progenitor cells, but the amounts needed can only be made from stem cells such as iPS cells. A new study by CiRA Associate Professor Hidetoshi Sakurai and colleagues report two cell surface receptors, CDH13 and FGFR4, that are expected to advance iPS cell therapies for these diseases. ....

Mingming Zhao , Akitsu Hotta , Naoshi Sugimoto , Antonio Lucena Cacace , Tatsuya Jonouchi , Hidetoshi Sakurai , Takuma Mizusawa , Mitsuru Sasaki Honda , Minas Nalbandian , Masahiko Yasuda , Yoshinori Yoshida , Department Of Clinical Application , Kyoto University , Central Institute For Experimental Animals , Department Of Cell Growth , Professor Hidetoshi Sakurai , Stem Cell , Myogenic Cell Purification Toward , Clinical Application , Cell Growth , Experimental Animals , அன்டோனியோ ழூசெனா காஸாஸ் , துறை ஆஃப் மருத்துவ விண்ணப்பம் , கியோட்டோ பல்கலைக்கழகம் , மைய நிறுவனம் க்கு சோதனை விலங்குகள் , துறை ஆஃப் செல் வளர்ச்சி ,